CDK Global (CDK) Tops Q3 EPS by 1c, Offers Guidance

CDK Global (NASDAQ: CDK) reported Q3 EPS of $0.69, $0.01 better than the analyst estimate of $0.68. Revenue for the quarter came in at $433.1 million versus the consensus estimate of $428.68 million.

GUIDANCE:

CDK Global sees FY2021 EPS of $2.50-$2.65, versus the consensus of $2.58. CDK Global sees FY2021 revenue of $1.66-1.7 billion, versus the consensus of $1.68 billion.

For earnings history and earnings-related data on CDK Global (CDK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c